Found: 8
Select item for more details and to access through your institution.
The role of PET/CT in thyroid autoimmune diseases.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 66, n. 3, p. 218, doi. 10.23736/S1824-4785.22.03464-1
- By:
- Publication type:
- Article
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 355, doi. 10.3390/cancers15020355
- By:
- Publication type:
- Article
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 4039, doi. 10.3390/cancers14164039
- By:
- Publication type:
- Article
<sup>18</sup>F-fluorocholine PET/CT semi-quantitative analysis in patients affected by primary hyperparathyroidism: a comparison between laboratory and functional data.
- Published in:
- Endocrine (1355008X), 2023, v. 80, n. 2, p. 433, doi. 10.1007/s12020-022-03280-9
- By:
- Publication type:
- Article
Comparison of Digital versus Analog 68 Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 23, p. 3535, doi. 10.3390/diagnostics13233535
- By:
- Publication type:
- Article
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 3, p. 564, doi. 10.3390/diagnostics13030564
- By:
- Publication type:
- Article
Predictors of Bone Metastases at 68 Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 6, p. 1309, doi. 10.3390/diagnostics12061309
- By:
- Publication type:
- Article
Event-free survival after <sup>68</sup> Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 9, p. 3257, doi. 10.1007/s00259-022-05741-9
- By:
- Publication type:
- Article